Upgrade to SI Premium - Free Trial

Coherus Oncology (CHRS)

1.45 -0.13 (8.23%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 Coherus Oncology, Inc. For: May 29 Filed by: McMichael Bryan J June 2, 2026 8:32 PM - SEC Filing Form 4 Coherus Oncology, Inc. For: May 29 Filed by: Lanfear Dennis M June 2, 2026 8:30 PM - SEC Filing Form 8-K Coherus Oncology, Inc. For: May 27 June 1, 2026 8:30 AM - SEC Filing Form DEFA14A Coherus Oncology, Inc. May 28, 2026 6:06 AM - SEC Filing Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: Timothy G. Youngquist 2020 Irrevocable Trust May 15, 2026 10:05 AM - SEC Filing Form 10-Q Coherus Oncology, Inc. For: Mar 31 May 11, 2026 4:44 PM - SEC Filing Form 8-K Coherus Oncology, Inc. For: May 11 May 11, 2026 4:17 PM - SEC Filing Coherus BioSciences (CHRS) Reports In-Line Q1 EPS May 11, 2026 4:05 PM - StreetInsider Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update May 11, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: Timothy G. Youngquist 2020 Irrevocable Trust May 11, 2026 9:21 AM - SEC Filing Guggenheim Starts Coherus Biosciences (CHRS) at Buy May 11, 2026 6:12 AM - StreetInsider Form DEFA14A Coherus Oncology, Inc. May 5, 2026 4:46 PM - SEC Filing Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 May 4, 2026 9:30 AM - Globe NewsWire Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: SATTERFIELD THOMAS A JR April 29, 2026 9:03 PM - SEC Filing Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: BlackRock, Inc. April 27, 2026 4:13 PM - SEC Filing Form ARS Coherus Oncology, Inc. For: Dec 31 April 20, 2026 8:59 AM - SEC Filing Form DEF 14A Coherus Oncology, Inc. For: May 27 April 20, 2026 8:27 AM - SEC Filing Form DEFA14A Coherus Oncology, Inc. April 14, 2026 5:21 PM - SEC Filing Form PRE 14A Coherus Oncology, Inc. For: May 27 April 9, 2026 5:26 PM - SEC Filing Form SCHEDULE 13G/A Coherus Oncology, Inc. Filed by: VANGUARD GROUP INC March 26, 2026 5:12 PM - SEC Filing Oppenheimer Reiterates Outperform Rating on Coherus Biosciences (CHRS): "buying opportunity ahead of key catalysts" March 10, 2026 8:15 AM - StreetInsider Full Article List